Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ronda Henry-Tillman

Concepts (259)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
40
2026
1223
4.500
Why?
Early Detection of Cancer
7
2026
190
2.330
Why?
Ultrasonography, Mammary
8
2020
61
1.850
Why?
Mass Screening
3
2020
362
1.380
Why?
Colorectal Neoplasms
4
2018
302
1.340
Why?
Mastectomy
13
2019
147
0.980
Why?
Healthcare Disparities
3
2017
312
0.980
Why?
Mastectomy, Segmental
7
2018
95
0.960
Why?
Sentinel Lymph Node Biopsy
10
2015
119
0.920
Why?
Community Health Planning
3
2018
28
0.890
Why?
Ultrasonography, Interventional
5
2020
138
0.760
Why?
Biopsy, Needle
10
2015
181
0.760
Why?
Focus Groups
1
2024
204
0.750
Why?
Neoplasm Staging
14
2024
774
0.750
Why?
Biopsy, Large-Core Needle
3
2020
34
0.740
Why?
Female
56
2026
28792
0.710
Why?
Lymph Nodes
7
2015
252
0.690
Why?
Genetic Counseling
1
2022
44
0.690
Why?
Neoplasms
5
2015
1335
0.680
Why?
Health Status Disparities
3
2015
221
0.670
Why?
Patient Education as Topic
1
2024
325
0.660
Why?
Image Interpretation, Computer-Assisted
1
2020
99
0.620
Why?
Middle Aged
41
2026
13422
0.610
Why?
Image-Guided Biopsy
2
2020
36
0.590
Why?
Hematoma
4
2018
67
0.580
Why?
Surgery, Computer-Assisted
2
2018
54
0.580
Why?
Humans
61
2026
53246
0.570
Why?
Polymorphism, Single Nucleotide
2
2018
505
0.570
Why?
Mandatory Programs
1
2018
22
0.540
Why?
Adiposity
1
2019
147
0.530
Why?
Faculty, Medical
3
2021
92
0.520
Why?
Adult
33
2026
14541
0.520
Why?
Health Care Costs
1
2018
178
0.510
Why?
Aged
31
2024
10430
0.500
Why?
Insurance Coverage
1
2018
124
0.490
Why?
Disease Management
1
2018
187
0.480
Why?
Diagnostic Imaging
1
2018
176
0.480
Why?
Minority Groups
3
2015
136
0.470
Why?
Arkansas
9
2018
2068
0.460
Why?
Retrospective Studies
19
2022
6821
0.430
Why?
Physicians
1
2018
242
0.430
Why?
Health Planning Councils
1
2014
6
0.410
Why?
Community-Based Participatory Research
2
2015
203
0.400
Why?
Rural Population
1
2017
597
0.370
Why?
Health Policy
1
2014
165
0.370
Why?
Follow-Up Studies
11
2018
2318
0.370
Why?
Aged, 80 and over
14
2018
3495
0.360
Why?
Qualitative Research
3
2024
384
0.350
Why?
Community Networks
2
2015
53
0.350
Why?
Community-Institutional Relations
1
2011
48
0.350
Why?
Primary Health Care
2
2024
404
0.340
Why?
Carcinoma, Ductal, Breast
4
2015
89
0.340
Why?
Carcinoma, Lobular
2
2015
32
0.330
Why?
Population Surveillance
1
2012
164
0.330
Why?
Physicians, Women
2
2021
20
0.320
Why?
Neoplasm Recurrence, Local
6
2014
647
0.310
Why?
Women's Health
1
2010
80
0.300
Why?
Health Education
2
2008
159
0.300
Why?
Needs Assessment
2
2024
145
0.290
Why?
Medical Oncology
1
2010
97
0.290
Why?
Breast Diseases
4
2018
25
0.280
Why?
Schools, Medical
2
2020
68
0.270
Why?
Nipples
5
2013
33
0.260
Why?
Health Knowledge, Attitudes, Practice
1
2012
523
0.260
Why?
Axilla
6
2015
92
0.260
Why?
Socioeconomic Factors
3
2018
623
0.260
Why?
Morbidity
2
2018
132
0.260
Why?
Physician-Patient Relations
2
2012
146
0.240
Why?
Health Services Accessibility
1
2011
477
0.240
Why?
Catheter Ablation
4
2014
124
0.230
Why?
Mammaplasty
3
2013
43
0.230
Why?
Lymphatic Metastasis
7
2015
211
0.230
Why?
Prognosis
9
2024
2118
0.230
Why?
Mentors
1
2006
57
0.230
Why?
Survivors
2
2024
120
0.220
Why?
Occult Blood
2
2017
23
0.220
Why?
United States
7
2022
5413
0.210
Why?
Magnetic Resonance Imaging
5
2014
1587
0.210
Why?
Young Adult
5
2024
4514
0.210
Why?
Papillomavirus Infections
1
2026
177
0.200
Why?
Referral and Consultation
2
2024
299
0.190
Why?
Education, Medical, Graduate
2
2022
219
0.190
Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.180
Why?
Zambia
4
2026
4
0.180
Why?
Male
13
2022
27444
0.180
Why?
Empathy
1
2002
46
0.180
Why?
HIV Infections
1
2026
402
0.170
Why?
Problem-Based Learning
1
2002
51
0.170
Why?
Emotions
1
2023
177
0.170
Why?
Atrial Fibrillation
1
2024
196
0.170
Why?
Breast
2
2020
87
0.170
Why?
Democratic Republic of the Congo
1
2020
4
0.170
Why?
Genetic Testing
1
2022
130
0.170
Why?
Combined Modality Therapy
4
2018
640
0.170
Why?
Dermatologic Surgical Procedures
3
2013
35
0.170
Why?
Counseling
1
2022
141
0.160
Why?
Feasibility Studies
2
2020
412
0.160
Why?
Biopsy, Fine-Needle
1
2020
104
0.160
Why?
Research Support as Topic
1
2020
44
0.160
Why?
Students, Medical
1
2002
157
0.150
Why?
General Surgery
1
2021
108
0.150
Why?
Surgical Flaps
2
2019
110
0.150
Why?
Prospective Studies
10
2024
2412
0.150
Why?
Obesity
1
2008
1205
0.150
Why?
Incidence
2
2024
1085
0.140
Why?
Patient Satisfaction
2
2019
292
0.140
Why?
Radiopharmaceuticals
4
2008
198
0.130
Why?
Diagnosis, Differential
1
2020
1038
0.130
Why?
Logistic Models
2
2018
947
0.130
Why?
Adipose Tissue
1
2019
210
0.130
Why?
Rural Health
1
2017
88
0.130
Why?
Lymphatic Vessels
2
2008
45
0.130
Why?
Internship and Residency
1
2022
439
0.120
Why?
Odds Ratio
1
2018
567
0.120
Why?
Mammography
1
2016
99
0.120
Why?
Rural Health Services
1
2018
179
0.120
Why?
Genetic Predisposition to Disease
1
2018
533
0.110
Why?
Cytodiagnosis
2
2013
42
0.110
Why?
Case-Control Studies
1
2018
1212
0.110
Why?
Cross-Sectional Studies
3
2021
1723
0.110
Why?
Risk Assessment
2
2018
1368
0.110
Why?
National Cancer Institute (U.S.)
1
2015
33
0.110
Why?
Survival Rate
1
2017
949
0.110
Why?
Uterine Cervical Neoplasms
1
2017
301
0.110
Why?
Algorithms
1
2018
668
0.110
Why?
Career Mobility
2
2021
29
0.100
Why?
Patient Care Planning
1
2013
69
0.100
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
47
0.100
Why?
Monitoring, Intraoperative
3
2014
51
0.090
Why?
Education, Medical
2
2006
111
0.090
Why?
Sigmoidoscopy
1
2012
10
0.090
Why?
Reagent Kits, Diagnostic
1
2012
16
0.090
Why?
Health Services
1
2012
71
0.090
Why?
Reproducibility of Results
1
2015
1221
0.080
Why?
Lymph Node Excision
4
2008
132
0.080
Why?
Colonoscopy
1
2012
107
0.080
Why?
Treatment Outcome
9
2017
5597
0.080
Why?
Receptors, Estrogen
2
2015
134
0.080
Why?
Feces
1
2012
160
0.080
Why?
Pancreatic Neoplasms
1
2013
219
0.080
Why?
Clinical Competence
1
2013
406
0.080
Why?
Lymphedema
2
2008
48
0.080
Why?
Fructose
1
2010
21
0.080
Why?
Patient Compliance
1
2012
232
0.080
Why?
Carbon
1
2010
60
0.080
Why?
Registries
1
2013
652
0.080
Why?
History, 21st Century
1
2010
60
0.080
Why?
Risk Factors
3
2024
4018
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1043
0.070
Why?
Carcinoma in Situ
2
2006
72
0.070
Why?
Delivery of Health Care
1
2011
317
0.070
Why?
Patient Acceptance of Health Care
1
2012
379
0.070
Why?
Models, Theoretical
2
2006
180
0.070
Why?
Prochlorperazine
1
2006
6
0.060
Why?
Postoperative Nausea and Vomiting
1
2006
20
0.060
Why?
Sensitivity and Specificity
3
2004
869
0.060
Why?
Antiemetics
1
2006
32
0.060
Why?
Education, Medical, Continuing
1
2006
76
0.060
Why?
Receptor, erbB-2
1
2006
79
0.060
Why?
Body Weights and Measures
1
2005
17
0.060
Why?
Predictive Value of Tests
2
2013
933
0.060
Why?
Biopsy
2
2004
600
0.060
Why?
Intraoperative Care
2
2003
51
0.060
Why?
Gadolinium
1
2005
47
0.060
Why?
Delivery of Health Care, Integrated
1
2026
61
0.060
Why?
Tissue Expansion Devices
1
2004
3
0.050
Why?
Neoadjuvant Therapy
2
2017
124
0.050
Why?
Interprofessional Relations
1
2006
95
0.050
Why?
Neuromuscular Agents
1
2004
8
0.050
Why?
Imaging, Three-Dimensional
1
2005
145
0.050
Why?
Botulinum Toxins, Type A
1
2004
15
0.050
Why?
Contrast Media
1
2005
178
0.050
Why?
Life Expectancy
1
2024
35
0.050
Why?
Cytological Techniques
1
2003
13
0.050
Why?
Anthracyclines
1
2024
35
0.050
Why?
Neoplasms, Multiple Primary
1
2003
44
0.050
Why?
Neoplasm Grading
2
2014
128
0.050
Why?
Pain, Postoperative
1
2004
169
0.050
Why?
Preoperative Care
3
2014
173
0.050
Why?
Surgical Instruments
1
2002
29
0.050
Why?
Foreign-Body Migration
1
2002
30
0.050
Why?
Humanism
1
2002
8
0.050
Why?
Life Change Events
1
2002
37
0.050
Why?
Confidence Intervals
1
2002
158
0.040
Why?
Career Choice
1
2002
116
0.040
Why?
Program Development
1
2002
165
0.040
Why?
Sexism
1
2021
11
0.040
Why?
Image Processing, Computer-Assisted
1
2002
235
0.040
Why?
Leadership
1
2021
106
0.040
Why?
Neoplasm Invasiveness
2
2010
281
0.040
Why?
Vacuum
2
2011
11
0.040
Why?
Curriculum
1
2002
409
0.040
Why?
Stereotaxic Techniques
2
2010
41
0.030
Why?
Angiopoietin-1
1
2017
16
0.030
Why?
Receptor, TIE-2
1
2017
16
0.030
Why?
Angiopoietin-2
1
2017
17
0.030
Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
Why?
Gene Frequency
1
2017
97
0.030
Why?
Injections, Intralesional
2
2008
32
0.030
Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
Why?
Adolescent
3
2013
6912
0.030
Why?
Vascular Endothelial Growth Factor A
1
2017
189
0.030
Why?
Guidelines as Topic
1
2016
111
0.030
Why?
Regression Analysis
1
2017
391
0.030
Why?
Neovascularization, Pathologic
1
2017
158
0.030
Why?
Coloring Agents
2
2007
65
0.030
Why?
Radionuclide Imaging
2
2007
107
0.030
Why?
Educational Status
1
2016
229
0.030
Why?
Genotype
1
2017
563
0.030
Why?
Taxoids
1
2015
38
0.030
Why?
Receptors, Progesterone
1
2015
68
0.030
Why?
Cohort Studies
2
2011
1557
0.030
Why?
Cyclophosphamide
1
2015
178
0.030
Why?
Touch
1
2013
23
0.030
Why?
Ultrasonography, Doppler
1
2014
42
0.030
Why?
Carcinoma
1
2015
136
0.020
Why?
Angiogenesis Inhibitors
1
2015
186
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2015
238
0.020
Why?
Disease-Free Survival
1
2014
466
0.020
Why?
Kaplan-Meier Estimate
1
2014
487
0.020
Why?
Cicatrix
1
2011
43
0.020
Why?
Microscopy, Phase-Contrast
1
2010
8
0.020
Why?
Plant Lectins
1
2010
8
0.020
Why?
Glycosylation
1
2010
104
0.020
Why?
Substrate Specificity
1
2010
197
0.020
Why?
Actins
1
2010
114
0.020
Why?
Tumor Cells, Cultured
1
2010
441
0.020
Why?
Cell Movement
1
2010
279
0.020
Why?
Breast Neoplasms, Male
1
2009
7
0.020
Why?
Pilot Projects
1
2011
727
0.020
Why?
Arm
1
2008
47
0.020
Why?
Phenotype
1
2010
803
0.020
Why?
Cost-Benefit Analysis
1
2008
274
0.020
Why?
Positron-Emission Tomography
1
2008
299
0.020
Why?
Administration, Rectal
1
2006
10
0.020
Why?
Cell Line, Tumor
1
2010
1470
0.010
Why?
Primary Prevention
1
2006
44
0.010
Why?
Probability
1
2006
171
0.010
Why?
Drug Administration Schedule
1
2006
370
0.010
Why?
Administration, Oral
1
2006
456
0.010
Why?
Carcinoma, Ductal
1
2004
7
0.010
Why?
Tissue Expansion
1
2004
4
0.010
Why?
Pectoralis Muscles
1
2004
6
0.010
Why?
Rectus Abdominis
1
2004
10
0.010
Why?
Spasm
1
2004
9
0.010
Why?
Multivariate Analysis
1
2006
598
0.010
Why?
Laser Coagulation
1
2004
26
0.010
Why?
Cryosurgery
1
2004
36
0.010
Why?
Sampling Studies
1
2004
38
0.010
Why?
Statistics, Nonparametric
1
2004
198
0.010
Why?
Chi-Square Distribution
1
2004
291
0.010
Why?
Injections
1
2003
59
0.010
Why?
Pain Measurement
1
2004
259
0.010
Why?
Dose-Response Relationship, Drug
1
2006
1367
0.010
Why?
Ultrasonography
1
2004
426
0.010
Why?
Length of Stay
1
2004
684
0.010
Why?
Reoperation
1
2002
476
0.010
Why?
Analgesics, Opioid
1
2004
622
0.010
Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description